Anti-human immunodeficiency virus-1 antibody titers in injection drug users compared to sexually infected individuals
Mem. Inst. Oswaldo Cruz
;
98(2): 209-212, Mar. 15, 2003. tab, graf
Article
Dans Anglais
| LILACS
| ID: lil-334256
ABSTRACT
Sera from infected injection drug users (IDU) have shown to have antibodies against synthetic human immunodeficiency virus-1 (HIV-1) envelope peptides more frequently. In this study, reactivity of 48 IDU plasma were compared to 60 plasmas obtained from sexually infected individuals (S). The overall reactivity of plasma from IDU compared to S was higher, and the reactivity titers were much higher for IDU plasma than S. IDU plasma also showed a broader antibody response. The higher reactivity titers were observed mainly for the gp41 immunodominant epitope and V3 peptides corresponding to the consensus sequences of HIV-1 subtypes/variants prevalent in Brazil (B, F, C) indicating the specificity in the higher immune response of IDU
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Fragments peptidiques
/
Anticorps anti-VIH
/
Protéine d'enveloppe gp41 du VIH
/
Protéine d'enveloppe gp120 du VIH
/
Infections à VIH
/
VIH-1 (Virus de l'Immunodéficience Humaine de type 1)
Type d'étude:
Étude pronostique
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Mem. Inst. Oswaldo Cruz
Thème du journal:
Médecine tropicale
/
Parasitologie
Année:
2003
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Fiocruz/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS